Follow-The-Filings

Security · featured owners

WGS Genedx Holdings Corp.

Health Care COM CL A Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 10.0%
  • $439M
  • 2 add 2 exits

WGS (Genedx Holdings Corp.) is held in 2 featured 13F books as of 2026 Q2. Corvex Management is the largest tracked holder by portfolio weight (10.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 10.0% (Corvex Management) · not free-float ownership

  1. Corvex Management Add 10.0%
  2. Cathie Wood Add 0.72%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Corvex Management 2026 Q2 10.0% Add +48.2% 4,784,570 $328M History
Cathie Wood - Ark Investment Management 2026 Q2 0.72% Add +21.6% 1,610,189 $111M History
Polen Capital Management exited 2026 Q2 Last 2026 Q1 0.03% Exit −0.03% 77,419 $5M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 5,000 $321K History

2 current · 2 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 15 rows shown

Filed Form Detail Links
4 Period Sep 16, 2026 Filing Doc
4 Period Sep 17, 2026 Filing Doc
4 Period Sep 16, 2026 Filing Doc
4 Period Sep 9, 2026 · 2 forms Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Jun 29, 2026 Filing Doc
4 Period Jun 18, 2026 · 7 forms Filing Doc
4 Period Jun 16, 2026 · 2 forms Filing Doc
4 Period Jun 9, 2026 · 2 forms Filing Doc
4 Period Jun 4, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period May 13, 2026 Filing Doc
4 Period May 7, 2026 · 2 forms Filing Doc
4 Period Apr 29, 2026 Filing Doc

Updated 11 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $202.57M $305.45M $427.54M
Gross profit $90.01M $194.4M $298.17M
Gross margin * 44.4% 63.6% 69.7%
Net income -$175.77M -$52.29M -$21.02M
Net margin * -86.8% -17.1% -4.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $182.34M $197.97M $268.29M
Total non-current assets * $236.42M $221.41M $255.42M
Total assets $418.76M $419.38M $523.71M
Total current liabilities $58.82M $54.82M $108.91M
Total non-current liabilities * $131.92M $119.32M $106.62M
Total equity $228.02M $245.25M $308.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$180.15M -$28.5M $33.28M
Cash from investing -$43.73M -$30.13M -$61.52M
Cash from financing $186.24M $44.16M $48.02M
Net change in cash -$37.64M -$14.47M $19.79M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders